Diagnostics
Independent Study Data Shows Noninvasive Test Could Eliminate the Biopsy Needle, Lower Patient Anxiety and Costs
SenzaGen has been notified by the European Center for the Validation of Alternative Methods (ECVAM) authority that due to time constrains their scientific committee (ESAC) will not be able to evaluate tests in the category ”Test Guidelines on Health Effects”, to which GARDskin belongs, this year.
SenzaGen announced today that the company will launch GARDair, the first in vitro test for airway allergies at ESTIV2018, the 20th International Congress on In Vitro Toxicology.
Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs
Owlstone Medical Ltd. announced today the addition of Dr Andy Richards CBE to its Board as a Non-Executive Director.
Flagship Biosciences’ MuscleMap algorithm that supports therapeutic development for DMD, a fatal neuromuscular disease, has been validated to be as effective as manual pathology.
Expedeon AG today announced the signing of a licence and supply agreement for its colloidal gold with South Korea-based PaxGenBio, a privately held, independent developer and supplier of rapid, highly sensitive multiplex diagnostic kits.
Concern Tecmash (part of Rostec) has presented the first sample of modernized Angel automated diagnostic and therapeutic system for human life support at the BIOTECHMED forum.
RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed second closing of its Series B round.
Lunaphore Technologies SA and A. Menarini Diagnostics S.r.l. today jointly announce the start of a strategic partnership bringing to the market a new and innovative system, using Lunaphore’s technology.
PRESS RELEASES